# Kingsley Advani

> Kingsley Advani is a seed investor at ALLO (San Francisco) backing FinTech and Financial Services. See 45 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [ALLO](https://shizune.co/investors/profile/allo-6725)
- Location: San Francisco, United States
- Total investments: 45
- Last investment: Aug 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kadvani
- Website: https://x.com/kadvani
- Facebook: https://www.facebook.com/king09

Kingsley Advani (born October 24, 1993, in London, United Kingdom) is a British tech entrepreneur, investor, and author based in Dubai, United Arab Emirates. He is the Founder and CEO of Allo, an exchange for tokenized stocks managing over $2 billion in tokenized real-world assets, and the founder of Allocations, a fintech platform that has grownto administer more than $2 billion in assets across 30,000+ high-net-worth clients.Advani began his entrepreneurial journey at the age of 13, launching a digital commerce business on eBay, before discovering Bitcoin in 2011 while studying finance and economics. In 2013, he allocated his IBM internship savings into Bitcoin and other emerging cryptocurrencies, becoming an early investor in what later became a multi-billion-dollar asset class. By his mid-twenties, he had invested in more than 200 companies, including unicorns such as SpaceX, Solana, Coinbase, Robinhood, and eToro.In 2017, he co-founded a global investor syndicate that collectively managed more than $4 billion in assets. Two years later, he launched Allocations, a platform providing infrastructure for fund administration, SPVs, and private market investments. CNBC recognized him as the “Blockchain Oracle” for his early insights into cryptocurrency adoption and market trends.Through his ventures, Advani has become a leading voice in fintech, blockchain, tokenization, private markets, and Web3, with frequent speaking engagements at global conferences including the SF Blockchain Summit, Beyond Blocks, Coinfest Asia, and the Ritossa Summit in Dubai. His commentary emphasizes how blockchain and emerging technologies can democratize access to alternative assets and reduce the barriers to launching micro-funds.Advani is also the author of The Blockchain Oracle: How Technology, Finance, and Vision Shape the Future of Global Investing (2025), a book that explores the intersection of blockchain, fintech, and global finance.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $120k–$4.3M |
| Pre-Seed | $120k–$4.5M |
| Series A | $4M–$183M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| FinTech | 11 | 24% |
| Financial Services | 9 | 20% |
| Biotechnology | 8 | 18% |
| Aerospace | 7 | 16% |
| Blockchain | 7 | 16% |

65 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 20 | 44% |
| Pre-Seed | 6 | 13% |
| Series A | 5 | 11% |
| Series B | 3 | 7% |
| Series C | 2 | 4% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 30 | 67% |
| Singapore | 2 | 4% |
| United Kingdom | 2 | 4% |
| China | 1 | 2% |
| Canada | 1 | 2% |

8 countries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Allocations | Allocations is a technology company building a private equity & venture capital economy that is open to all, enabling more financial inclusion for every person and business. Allocations has raised in excess of $7m from over 200 investors as of August 2021 including Irish Angels, Vitalize VC, Allocations Angels, LFG Ventures, Browder Capital,TVC, Jamie Rogozinski, Joey Krug, Bruce Menin and Russell Galbut. To date Allocations has powered over 300 private funds, totaling approximately $250m in volume. | $4M | Series A | Aug 05, 2021 |  |
| Allocations | Allocations is a technology company building a private equity & venture capital economy that is open to all, enabling more financial inclusion for every person and business. Allocations has raised in excess of $7m from over 200 investors as of August 2021 including Irish Angels, Vitalize VC, Allocations Angels, LFG Ventures, Browder Capital,TVC, Jamie Rogozinski, Joey Krug, Bruce Menin and Russell Galbut. To date Allocations has powered over 300 private funds, totaling approximately $250m in volume. | $4M | Seed | Aug 05, 2021 |  |
| Checkstep | CheckStep provides a AI-powered Trust & Safety and UGC management software to online platform worldwide. It enables company to manage the full policy management life-cycle. | $430K | Pre-Seed | Jun 28, 2021 |  |
| Allocations | Allocations is a technology company building a private equity & venture capital economy that is open to all, enabling more financial inclusion for every person and business. Allocations has raised in excess of $7m from over 200 investors as of August 2021 including Irish Angels, Vitalize VC, Allocations Angels, LFG Ventures, Browder Capital,TVC, Jamie Rogozinski, Joey Krug, Bruce Menin and Russell Galbut. To date Allocations has powered over 300 private funds, totaling approximately $250m in volume. | $1M | Seed | Aug 31, 2020 |  |
| Allocations | Allocations is a technology company building a private equity & venture capital economy that is open to all, enabling more financial inclusion for every person and business. Allocations has raised in excess of $7m from over 200 investors as of August 2021 including Irish Angels, Vitalize VC, Allocations Angels, LFG Ventures, Browder Capital,TVC, Jamie Rogozinski, Joey Krug, Bruce Menin and Russell Galbut. To date Allocations has powered over 300 private funds, totaling approximately $250m in volume. | $1M | Pre-Seed | Aug 31, 2020 |  |
| Ashvattha Therapeutics | Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology. | $22M | Convertible Note | May 31, 2020 |  |
| OncoSenX | OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more preciseintervention for this complex and devastating disease. | $4.5M | Pre-Seed | Apr 01, 2020 |  |
| New Age Meats | New Age Meats is a biotechnology company that develops healthy cultivated meat grown from animal cells instead of animal slaughter. | $2.7M | Seed | Jan 09, 2020 |  |
| Volumetric | Volumetric is an advanced biomaterials and biofabrication company that develops a 3D bioprinting platform intended to create materials with living cells with applications in biomaterials, cancer research, and human organ replacements. | $1.8M | Seed | Nov 19, 2019 |  |
| Orbit Fab | Orbit Fab offers a supply of satellite propellant in Earth Orbit that expands the operational potential of new and existing space assets. It develops the infrastructure needed to grow a thriving in-space market for products and services that support both existing space businesses (communications and Earth observation) and new industries like spacetourism, manufacturing, and mining. The future for satellites is no longer restricted to the fuel they are launched with. Orbit Fab was founded in 2018 by its Co-Founders Daniel Faber and Jeremy Schiel. | $3.3M | Seed | Oct 04, 2019 |  |

10 of 45 investments shown.

## Co-investors
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 10 deals together
- [Helios Capital](https://shizune.co/investors/profile/helios-capital-1131) — VC Fund, 8 deals together
- [Chainfund Capital](https://shizune.co/investors/profile/blockchain-fund) — VC Fund, 6 deals together
- [Tribe Capital](https://shizune.co/investors/profile/tribe-capital) — VC Fund, 5 deals together
- [Fort Ventures](https://shizune.co/investors/profile/fort-ventures) — VC Fund, 3 deals together
- [9Yards Capital](https://shizune.co/investors/profile/9yards-capital) — VC Fund, 2 deals together

## About ALLO

VC Fund · Dubai, United Arab Emirates

Allo is a platform for tokenization. The technology facilitates on-chain lending and tokenization of real-world assets.

2 contacts available at ALLO.

| Name | Title | Profile |
| --- | --- | --- |
| Guillaume Duhan | CTO & Co-Founder | https://shizune.co/investors/profile/guillaume-duhan |
| Kingsley Advani | CEO & Founder | https://shizune.co/investors/profile/kingsley-advani |

## Similar investors

### Similar industry
- [Casa Verde Capital](https://shizune.co/investors/profile/casa-verde-capital) — VC Fund
- [Poseidon Asset Management](https://shizune.co/investors/profile/poseidon-assetmanagement) — VC Fund
- [Phyto Partners](https://shizune.co/investors/profile/phyto-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Health Care Angel Investors](https://shizune.co/investors/health-care-angel-investors)
- [Biotech Angel Investors](https://shizune.co/investors/biotech-angel-investors)
- [Health Care Angel Investors in United States](https://shizune.co/investors/health-care-angel-investors-united-states)
- [Biotech Angel Investors in United States](https://shizune.co/investors/biotech-angel-investors-united-states)
- [Biotechnology Angel Investors](https://shizune.co/investors/biotechnology-angel-investors)
- [Finance Angel Investors](https://shizune.co/investors/finance-angel-investors)

## FAQ

### What does Kingsley Advani invest in?

Kingsley Advani invests primarily in FinTech, Financial Services and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Kingsley Advani's check size?

Kingsley Advani typically joins rounds of $120k–$4.3M at Seed, $120k–$4.5M at Pre-Seed and $4M–$183M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kingsley Advani participates in.

### When did Kingsley Advani last invest?

The most recent investment recorded for Kingsley Advani closed in Aug 2021. Shizune tracks 45 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co